It comes as Queensland Police confirmed the 40-year-old man developed deep-vein thrombosis in 2010, a year after knee surgery.
It was previously reported the officer had recently undergone the surgery.
Federal health authorities are now working to establish if there is a connection between the vaccination and the blood clots he developed shortly after.
Pfizer said it had undergone a “comprehensive assessment of ongoing aggregate safety data” for its vaccine, and said blood clots aren’t a risk identified with receiving the jab.”
“(The assessment) provided no evidence to conclude that arterial or venous thromboembolic events (blood clots), with or without thrombocytopenia, are a risk associated with the use of our COVID-19 vaccine,” the statement said.
The officer recovered and is now back on duty.
“(For over 50s) we recommend AstraZeneca, the risk-benefit for over 50 is vastly in favour of being vaccinated,” Secretary of the Department of Health Brendan Murphy said.